-
Vaptans Market Set to Register a CAGR of 4.7% and Reach US$ 2.72 Billion by 2031 | Growth Plus Reports
24 Apr 2023 06:30 GMT
… segmented into selective vaptans and nonselective vaptans. The nonselective vaptan segment accounts for … CATEGORIES
Selective Vaptans
Tolvaptan
Lixivaptan
Others
Nonselective Vaptans
GLOBAL VAPTANS MARKET - ANALYSIS …
-
Vaptans Market Set to Register a CAGR of 4.7% and Reach US$ 2.72 Billion by 2031 | Growth Plus Reports
24 Apr 2023 07:38 GMT
… segmented into selective vaptans and nonselective vaptans. The nonselective vaptan segment accounts for … CATEGORIES
Selective Vaptans
Tolvaptan
Lixivaptan
Others
Nonselective Vaptans
GLOBAL VAPTANS MARKET - ANALYSIS …
-
Evaluation of Diuretic Activity of Aqueous and Hydro Methanolic Crude Extracts and Solvent Fraction of the Hydromethanolic Flower Extract of Erica Arborea L. (Ericaceae) in Swiss Albino Mice
18 Apr 2024 12:22 GMT
… .7 Although newer drugs like vaptans and Vasopressin receptor (V2R) antagonist …
-
Identification of Shared Signature Genes and Immune Microenvironment Subtypes for Heart Failure and Chronic Kidney Disease Based on Machine Learning
21 Mar 2024 04:56 GMT
… : role of Arginine Vasopressin and Vaptans in Heart Failure. Cardiol Res …
-
What’s Changing on the 2024 WADA Prohibited Doping List?
06 Nov 2023 16:30 GMT
… added as further examples of vaptan drugs.
S6. Stimulants
Beta-methylphenethylamine …
-
Hepatic Cirrhosis Market Evolving at a Rapid Pace, Predicts DelveInsight | Key Companies Active in the Domain - Madrigal, Zydus, Can-Fite BioPharma, Bristol-Myers Squibb, Boehringer Ingelheim, Grifols, Akero
27 Apr 2023 17:00 GMT
… are also given statins and vaptans. Tolvaptan is recommended for hepatic …
-
Empagliflozin Eyed for Outpatient Chronic Hyponatremia
21 Jun 2022 16:06 GMT
… , Monnerat observed.
Vasopressin receptor antagonists (vaptans) are very effective, but also …
-
Cumberland Pharmaceuticals Inc. (CPIX) CEO A.J. Kazimi on Q1 2022 Results - Earnings Call Transcript
14 May 2022 21:48 GMT
… is the only intravenously administered Vaptan treatment available in the United …
-
Cumberland Pharmaceuticals Inc.'s (CPIX) CEO A.J. Kazimi on Q4 2021 Results - Earnings Call Transcript
09 Mar 2022 05:31 GMT
… the use of an intravenous vaptan to treat hyponatremia in critically … is the only intravenously administered vaptan treatment available in the United …